These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 8200964

  • 1. Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase.
    Laitala T, Väänänen HK.
    J Clin Invest; 1994 Jun; 93(6):2311-8. PubMed ID: 8200964
    [Abstract] [Full Text] [Related]

  • 2. Proton channel part of vacuolar H(+)-ATPase and carbonic anhydrase II expression is stimulated in resorbing osteoclasts.
    Laitala T, Väänänen K.
    J Bone Miner Res; 1993 Jan; 8(1):119-26. PubMed ID: 8427045
    [Abstract] [Full Text] [Related]

  • 3. Decreased bone resorption, osteoclast differentiation, and expression of vacuolar H+-ATPase in antisense DNA-treated mouse metacarpal and calvaria cultures ex vivo.
    Laitala-Leinonen T, Väänänen HK.
    Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):155-69. PubMed ID: 10355822
    [Abstract] [Full Text] [Related]

  • 4. Membrane-bound carbonic anhydrases in osteoclasts.
    Riihonen R, Supuran CT, Parkkila S, Pastorekova S, Väänänen HK, Laitala-Leinonen T.
    Bone; 2007 Apr; 40(4):1021-31. PubMed ID: 17291844
    [Abstract] [Full Text] [Related]

  • 5. Characterization and cellular distribution of the osteoclast ruffled membrane vacuolar H+-ATPase B-subunit using isoform-specific antibodies.
    Mattsson JP, Skyman C, Palokangas H, Väänänen KH, Keeling DJ.
    J Bone Miner Res; 1997 May; 12(5):753-60. PubMed ID: 9144341
    [Abstract] [Full Text] [Related]

  • 6. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application.
    Niikura K, Takeshita N, Takano M.
    J Bone Miner Res; 2005 Sep; 20(9):1579-88. PubMed ID: 16059630
    [Abstract] [Full Text] [Related]

  • 7. The regulation of pHi in osteoclasts is dependent on the culture substrate and on the stage of the resorption cycle.
    Lehenkari PP, Laitala-Leinonen T, Linna TJ, Väänänen HK.
    Biochem Biophys Res Commun; 1997 Jun 27; 235(3):838-44. PubMed ID: 9207248
    [Abstract] [Full Text] [Related]

  • 8. Immunolocalization of CA II and H+ V-ATPase in epithelial cells of the mouse and rat epididymis.
    Hermo L, Adamali HI, Andonian S.
    J Androl; 2000 Jun 27; 21(3):376-91. PubMed ID: 10819445
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of intravacuolar acidification by antisense RNA decreases osteoclast differentiation and bone resorption in vitro.
    Laitala-Leinonen T, Löwik C, Papapoulos S, Väänänen HK.
    J Cell Sci; 1999 Nov 27; 112 ( Pt 21)():3657-66. PubMed ID: 10523502
    [Abstract] [Full Text] [Related]

  • 10. Concanamycin B, a vacuolar H(+)-ATPase specific inhibitor suppresses bone resorption in vitro.
    Woo JT, Ohba Y, Tagami K, Sumitani K, Yamaguchi K, Tsuji T.
    Biol Pharm Bull; 1996 Feb 27; 19(2):297-9. PubMed ID: 8850326
    [Abstract] [Full Text] [Related]

  • 11. Carbonic anhydrase II mRNA expression in individual osteoclasts under "resorbing" and "nonresorbing" conditions.
    Asotra S, Gupta AK, Sodek J, Aubin JE, Heersche JN.
    J Bone Miner Res; 1994 Jul 27; 9(7):1115-22. PubMed ID: 7942159
    [Abstract] [Full Text] [Related]

  • 12. [3H]Bafilomycin as a probe for the transmembrane proton channel of the osteoclast vacuolar H(+)-ATPase.
    Mattsson JP, Keeling DJ.
    Biochim Biophys Acta; 1996 Apr 03; 1280(1):98-106. PubMed ID: 8634321
    [Abstract] [Full Text] [Related]

  • 13. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
    David P, Nguyen H, Barbier A, Baron R.
    J Bone Miner Res; 1996 Oct 03; 11(10):1498-507. PubMed ID: 8889850
    [Abstract] [Full Text] [Related]

  • 14. Vacuolar H+-ATPase activity and expression in mouse bone marrow cultures.
    Lee BS, Holliday LS, Krits I, Gluck SL.
    J Bone Miner Res; 1999 Dec 03; 14(12):2127-36. PubMed ID: 10620072
    [Abstract] [Full Text] [Related]

  • 15. Specific inhibitors of vacuolar H(+)-ATPase trigger apoptotic cell death of osteoclasts.
    Okahashi N, Nakamura I, Jimi E, Koide M, Suda T, Nishihara T.
    J Bone Miner Res; 1997 Jul 03; 12(7):1116-23. PubMed ID: 9200012
    [Abstract] [Full Text] [Related]

  • 16. Resorption-cycle-dependent polarization of mRNAs for different subunits of V-ATPase in bone-resorbing osteoclasts.
    Laitala-Leinonen T, Howell ML, Dean GE, Väänänen HK.
    Mol Biol Cell; 1996 Jan 03; 7(1):129-42. PubMed ID: 8741845
    [Abstract] [Full Text] [Related]

  • 17. Relative roles of Na+/H+ exchange and vacuolar-type H+ ATPases in regulating cytoplasmic pH and function in murine peritoneal macrophages.
    Swallow CJ, Grinstein S, Sudsbury RA, Rotstein OD.
    J Cell Physiol; 1993 Dec 03; 157(3):453-60. PubMed ID: 8253856
    [Abstract] [Full Text] [Related]

  • 18. Vacuolar-type H+-ATPase-mediated acidosis promotes in vitro osteoclastogenesis via modulation of cell migration.
    Kim JM, Min SK, Kim H, Kang HK, Jung SY, Lee SH, Choi Y, Roh S, Jeong D, Min BM.
    Int J Mol Med; 2007 Mar 03; 19(3):393-400. PubMed ID: 17273786
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase.
    Gagliardi S, Gatti PA, Belfiore P, Zocchetti A, Clarke GD, Farina C.
    J Med Chem; 1998 May 21; 41(11):1883-93. PubMed ID: 9599238
    [Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+.
    Lehenkari P, Hentunen TA, Laitala-Leinonen T, Tuukkanen J, Väänänen HK.
    Exp Cell Res; 1998 Jul 10; 242(1):128-37. PubMed ID: 9665810
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.